Orhan ALTINBOĞA, Banu SEVEN, Nihan GÜNERİ, İsmail Burak GÜLTEKİN, Elif AKKAŞ YILMAZ

PELVİK İNFLAMATUAR HASTALIKTA GENÇ YAŞ BASKINLIĞI İLERİ YAŞ LEHİNE DEĞİŞİYOR MU?

ÖZET Amaç: Üçüncü basamak bir referans hastanesinde pelvik inflamatuar hastalık insidansı ve dağılımını araştır- mak. Materyal ve Metod: 2008 ve 2012 yılları arasında, 4 yıllık dönemdeki elektronik hasta dosyaları retrospektif olarak tarandı. Çalışmaya toplam 2.235 kadın hasta dahil edildi. İncelenen ana değişkenler yaş gruplarına göre insidans ve dağılım olarak belirlendi. Sonuç: Çalışmaya dahil edilen 2.235 kadının %43,4ü 35 yaş üzeri, %18,2si 30-35 yaş aralığında, %23ü 25- 30 yaş aralığında, %9,3ü 20-24 yaş aralığında ve %6sı 20 yaş altı olarak bulundu. Kullanılan kontrasepsiyon yöntemleri ve oranları %18 rahim içi araç (RİA), %5,2 kombine oral kontraseptifler, %10 kondom, %3,2 cerrahi sterilizasyon ve %26,1 geri çekme yöntemi olarak bulundu. Vajinal duş kullanım insidansı %57 oranında iken, bu uygulamayı kadınların %59unun cinsel ilişki sonrası uyguladığı saptandı. Vajinal duş uygulamasının yaş gruplarına göre dağılımında adolesanlarda (

Is the Young age Predominance for Pelvic Inflammatory Disease Changing in Favor of Older age Group?

Objectives: To find out pelvic inflammatory disease (PID) incidence and distribution among different age groups at a tertiary referral hospital. Material and Methods: Subjects were gathered prospectively from the electronic medical files of female patients seen as inpatients over a period of 4 years (between 2008 and 2012). A total of 2,235 patients were included within the study and were reviewed in depth. The main outcome measures were the incidence and distribution among different age groups. Results: Out of 2,235 women included within the study 43.4% were above 35 years of age, 18.2% were between 30-35 years of age, 23% were between 25-30 years of age, 9.3% were between 20-24 years of age and 6% were less than 20 years of age. The percentages of contraceptive methods being used were 18% intrauterine device (IUD), 5.2% combined oral contraceptives (OC), 10% condom, 3.2% surgical sterilization and 26.1% coitus interruptus (CI). Vaginal douching (VD) incidence was 57% with 59% performing this practice after the coitus. The distribution of vaginal douching for age groups were 40.4% for adolescents (

PDF

___

1. Paavonen J, Molander P. Pelvic inflammatory disease. Gynecology, Third Edition, Ed: RW Shaw, WPSoutter, SL Stanton. Churchill Livingstone, p 891. 2. Kelly AM, Ireland M, Aughey D. Pelvic inflammatory disease in adolescents: High incidence andrecurrence rates in an urban teen clinic. J Pediatr Adolesc Gynecol 2004;17(6):383-8. 3. Microbial etiology of urban emergency department acute salpingitis: treatment with ofloxacin.Soper DE, Brockwell NJ, Dalton HP.Am J Obstet Gynecol. 1992 Sep;167(3):653-60. 4. Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin.Wasserheit JN, Bell TA, Kiviat NB, Wølner-Hanssen P, Zabriskie V, Kirby BD, Prince EC, Holmes KK, Stamm WE, Eschenbach DA.Ann Intern Med. 1986 Feb;104(2):187-93. 5. Hillis SD, Joesoef R, Marchbanks PA, Wasserheit JN, Cates W Jr, Westrom L.Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility.Am J Obstet Gynecol. 1993 May;168(5):1503-9. 6. Washington AE, Cates W, Wasserheit JN. Preventing pelvic inflammatory disease. JAMA 1991;18:2574. 7. Soper. D.E.Genitourinary Infections and Sexually Transmitted Diseases In: Berek.J .S. Berek and Novaks Gynecology .USA.Lippincott Williams&Wilkins 2012. P:565 8. Wolner-Hanssen P, Kiviat NB, Holmes KK. Atypical pelvic inflammatory disease: subacute, chronic, or subclinical upper genital tract infection in women. In: Holmes KK, Mardh P-A, Sparling PF, Wiesner. 9. PJ, Cates W, Lemon SM, Stamm WE (editors). Sexually transmitted diseases, 2nd ed. New York (NY): McGraw-Hill, 1990; 615-620. 10. Washington A, Wadsworth J, Wellings K, et al.Assessing risk for pelvic inflammatory disease and its sequelae.JAMA 1991 ;266:2581-6 11. Cates Jr W, Rolfs Jr R, Aral S.Sexually transmitted diseases, pelvic inflammatory disease, and infertility:an epidemiologic update.Epidemiol Rev 1990;12:199-220 12. İnfectious diseases of the female genitale tract .Lippincott Williams &Wilkins 2012c:13 s:221 13. Giray H, Kılıç B. Bekar kadınlar ve üreme sağlığı. STED 2004; 13 (8):286-289. 14. 2008 Türkiye Nüfus ve Sağlık Araştırması, HÜNEE, Sağlık Bakanlığı Ana Çocuk Sağlığı ve Aile Planlaması Genel Müdürlüğü, Başbakanlık Devlet Planlama Teşkilatı Müsteşarlığı ve TÜBİTAK, Ankara. 15. Jun Zhang, MB, PhD, A. George Thomas, MD, and Etel Leybovich, Vaginal Douching and Adverse Health Effects: A Meta-Analysis, American Journal of Public Health, July 1997, Vol. 87, No. 7,1207-1211. 16. Scholes D, Daling JR, Stergachis A, Weiss NS, Wang SP, Grayston JT. Vaginal douching as a risk factor for acute pelvic inflammatory disease. Obstet Gynecol. 1993 Apr;81(4):601-6.